IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Almac Group to invest $7 million in biocatalysis in Northern Ireland

10:11 AM MST | February 3, 2015 | Michael Ravenscroft

Almac (Craigavon, UK), a privately-owned contract development and manufacturing pharmaceutical services group, has announced a $7 million investment in in the area of biocatalyst discovery and development. The company is to collaborate with Queens University Belfast (QUB). Financial support is also being provided by Invest Northern Ireland, a regional business development agency. The project will run with QUB for three years and involve further development of biocatalysis services and products for various sectors, including active pharmaceutical ingredients...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa